Boston – The US Food and Drug Administration (FDA) has given the green light for the nationwide rollout of a second Covid19 vaccine.
Reports said an FDA advisory panel had endorsed the Emergency Use Authorization (EUA) for the Moderna vaccine one week after Pfizer-BioNTech’s was approved, thereby paving the way for mass distribution in the US.
Experts say the introduction of a second vaccine couldn’t have come at a more appropriate time, with the nation reeling from record numbers of Covid infections and deaths.
As of December 17, 2020, The New York Times said the US had chalked up 17.2 million cases and 310,000 deaths.
Moderna is expected to be widely welcomed as it is easier to circulate among the populace because it doesn’t require ultra-cold freezers like the Pfizer vaccine.
The Moderna vaccine is said to have an efficacy rating of 94 percent.